MiniMed (MMED) Common Equity (2025 - 2026)
MiniMed (MMED) posted Common Equity of $3.6 billion for Q3 2026, little changed quarter-over-quarter from $3.6 billion in Q2 2026, and up 2.35% YoY from $3.5 billion in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Common Equity (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Common Equity data on file, last reported at $3.6 billion in Q3 2026.
- For the quarter ending Q3 2026, Common Equity rose 2.35% year-over-year to $3.6 billion; the trailing twelve-month figure through Jul 2026 stood at $3.6 billion (up 2.35% YoY), and the FY2026 full-year result was $3.6 billion, up 8.44% from the prior year.
- Common Equity was $3.6 billion for Q3 2026 at MiniMed, roughly flat from $3.6 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $3.6 billion in Q3 2026 to a low of $3.3 billion in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 7.22 Bn |
| 10 | MiniMed | 6.55 Bn | 6.34 Bn | 465.00 Mn | 3.62 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 3.62 Bn |
| Apr 24, 2026 | 3.61 Bn |
| Jan 23, 2026 | 3.46 Bn |
| Apr 25, 2025 | 3.33 Bn |
| Jan 24, 2025 | 3.49 Bn |